Cauldron Ferm ads

The challenge isn't innovation. It's manufacturing at commercial scale. Cauldron helps close the gap with continuous fermentation.

Breakthrough science isn't enough. Commercial success depends on scale and process efficiency. Cauldron's continuous fermentation is built to bridge that gap.

Cauldron Ferm is traveling to Dalian next week for the World Economic Forum's Annual Meeting of the New Champions! Co-founder David Kestenbaum is looking forward to convening with global leaders to exchange perspectives under the theme of "Innovating at Scale." If you’re attending and advancing your bioeconomy strategy, planning biomanufacturing scale up, or navigating bio-product commercialisation, we’d love to connect. Follow along for updates from #AMNC26 #biomanufacturing #bioeconomy #industrialbiotech #WEFTechPioneer

Biomanufacturing holds enormous potential in food, materials, chemicals, and fuels. Realizing that potential requires a process that can operate continuously, reliably, and at commercial scale. That's what Cauldron has built. Is large-scale bioproduction part of your organization's roadmap?

Continuous hyper-fermentation makes high-volume biomanufacturing commercially viable across food, materials, and fuels. Our 30,000-liter facility is running now.

Third-party validation matters. But so does proven commercial impact. Cauldron's continuous hyper-fermentation process is operating at 10,000 liters and delivering the efficiency gains the industry has been waiting for.